• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance.

作者信息

De Luca Giuseppe, Di Lorenzo Emilio

机构信息

AOU Maggiore della Carità, Eastern Piedmont University, C.so Mazzini 18, 28100 Novara, Italy.

AOU Maggiore della Carità, Eastern Piedmont University, C.so Mazzini 18, 28100 Novara, Italy; Division of Cardiology, S.G. Moscati, Avellino, Italy.

出版信息

Int J Cardiol. 2016 Jan 1;202:940. doi: 10.1016/j.ijcard.2015.08.194. Epub 2015 Aug 30.

DOI:10.1016/j.ijcard.2015.08.194
PMID:26547665
Abstract
摘要

相似文献

1
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance.依维莫司洗脱支架与西罗莫司洗脱支架的预后意义比较
Int J Cardiol. 2016 Jan 1;202:940. doi: 10.1016/j.ijcard.2015.08.194. Epub 2015 Aug 30.
2
Everolimus-Eluting Stent versus Sirolimus-Eluting Stent for prognostic significance.依维莫司洗脱支架与西罗莫司洗脱支架的预后意义比较。
Int J Cardiol. 2016 Jan 1;202:939. doi: 10.1016/j.ijcard.2015.08.183. Epub 2015 Sep 14.
3
Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.随机比较依维莫司洗脱支架与西罗莫司洗脱支架治疗糖尿病患者新发冠状动脉疾病（ESSENCE-DIABETES）：来自 ESSENCE-DIABETES 试验的结果。
Circulation. 2011 Aug 23;124(8):886-92. doi: 10.1161/CIRCULATIONAHA.110.015453. Epub 2011 Aug 1.
4
Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.比较依维莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉疾病患者的临床安全性和疗效。
Ann Med. 2011 Feb;43(1):75-9. doi: 10.3109/07853890.2010.543924. Epub 2010 Dec 20.
5
Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease.无保护左主干冠状动脉疾病中使用佐他莫司洗脱支架与依维莫司洗脱支架的比较。
J Am Coll Cardiol. 2013 Dec 3;62(22):2075-82. doi: 10.1016/j.jacc.2013.07.044. Epub 2013 Aug 21.
6
Randomized comparison of sirolimus-eluting and everolimus-eluting coronary stents in the treatment of total coronary occlusions: results from the chronic coronary occlusion treated by everolimus-eluting stent randomized trial.随机比较西罗莫司洗脱和依维莫司洗脱冠状动脉支架治疗完全闭塞性冠状动脉病变：依维莫司洗脱支架治疗慢性完全闭塞病变随机试验的结果。
Circ Cardiovasc Interv. 2013 Feb;6(1):21-8. doi: 10.1161/CIRCINTERVENTIONS.112.000076. Epub 2013 Feb 12.
7
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.依维莫司和紫杉醇洗脱支架置入术后 3 年的临床随访：来自 SPIRIT II（依维莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估）和 SPIRIT III（依维莫司洗脱冠状动脉支架系统[EECSS]治疗初发冠状动脉病变患者的临床评估）随机试验的汇总分析。
JACC Cardiovasc Interv. 2010 Dec;3(12):1220-8. doi: 10.1016/j.jcin.2010.07.017.
8
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.依维莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉疾病患者的比较：一项随机试验。
JAMA. 2008 Apr 23;299(16):1903-13. doi: 10.1001/jama.299.16.1903.
9
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.多部位、多血管病变患者中应用依维莫司洗脱支架和紫杉醇洗脱支架的对比：SPIRIT III 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统（EECSS）的 XIENCE V 血管内介入器械的临床评估）和 SPIRIT IV 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统的 XIENCE V 血管内介入器械的临床评估）随机临床试验。
JACC Cardiovasc Interv. 2010 Dec;3(12):1229-39. doi: 10.1016/j.jcin.2010.09.014.
10
Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).经皮冠状动脉介入治疗患者中依维莫司洗脱支架与西罗莫司洗脱支架的随机比较：斯堪的纳维亚随机临床试验组织具有临床转归的 IV 期研究（SORT OUT IV）。
Circulation. 2012 Mar 13;125(10):1246-55. doi: 10.1161/CIRCULATIONAHA.111.063644. Epub 2012 Feb 3.